Literature DB >> 16798973

Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant.

Pierre Sidon, Pierre Heimann, Frédéric Lambert, Barbara Dessars, Valérie Robin, Hakim El Housni.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16798973     DOI： 10.1373/clinchem.2006.066886

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  9 in total

1.  High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms.

Authors:  Inmaculada Rapado; Silvia Grande; Enriqueta Albizua; Rosa Ayala; José-Angel Hernández; Miguel Gallardo; Florinda Gilsanz; Joaquin Martinez-Lopez
Journal:  J Mol Diagn       Date:  2009-03       Impact factor: 5.568

2.  Sensitive detection and quantification of the JAK2V617F allele by real-time PCR blocking wild-type amplification by using a peptide nucleic acid oligonucleotide.

Authors:  Cornelis J J Huijsmans; Jeroen Poodt; Paul H M Savelkoul; Mirjam H A Hermans
Journal:  J Mol Diagn       Date:  2011-06-30       Impact factor: 5.568

3.  High-throughput quantitative real-time polymerase chain reaction array for absolute and relative quantification of rhesus macaque types I, II, and III interferon and their subtypes.

Authors:  Lynnsie M Schramm; Kevin D Kirschman; Melissa Heuer; Aaron A Chen; Daniela Verthelyi; Montserrat Puig; Ronald L Rabin
Journal:  J Interferon Cytokine Res       Date:  2012-07-20       Impact factor: 2.607

4.  A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.

Authors:  Barbara Denys; Hakim El Housni; Friedel Nollet; Bruno Verhasselt; Jan Philippé
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

5.  Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders.

Authors:  Emma Hammond; Kathryn Shaw; Benedict Carnley; Stephanie P'ng; Ian James; Richard Herrmann
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

6.  Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia.

Authors:  Todd S Laughlin; Michael W Becker; Jane L Liesveld; Deborah A Mulford; Camille N Abboud; Patrick Brown; Paul G Rothberg
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

7.  Development of a highly sensitive method for detection of JAK2V617F.

Authors:  Anna H Zhao; Rufei Gao; Zhizhuang J Zhao
Journal:  J Hematol Oncol       Date:  2011-10-10       Impact factor: 17.388

8.  MPN patients harbor recurrent truncating mutations in transcription factor NF-E2.

Authors:  Jonas S Jutzi; Ruzhica Bogeska; Gorica Nikoloski; Corina A Schmid; Thalia S Seeger; Frank Stegelmann; Sven Schwemmers; Albert Gründer; Jan C Peeken; Monika Gothwal; Julius Wehrle; Konrad Aumann; Kamar Hamdi; Christine Dierks; Wei Kamar Wang; Konstanze Döhner; Joop H Jansen; Heike L Pahl
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

9.  Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection.

Authors:  Giada V Zapparoli; Robert N Jorissen; Chelsee A Hewitt; Michelle McBean; David A Westerman; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2013-04-24       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.